Afrăsânie, V.-A.; Rusu, A.; Gheorghe, A.S.; Froicu, E.M.; Dumitrescu, E.A.; Gafton, B.; Alexa-Stratulat, T.; Miron, L.; Stănculeanu, D.L.; Marinca, M.V.
Long-Term Survival in BRCA1 Mutant Advanced Ovarian Cancer: Unveiling the Impact of Olaparib. Diagnostics 2024, 14, 1898.
https://doi.org/10.3390/diagnostics14171898
AMA Style
Afrăsânie V-A, Rusu A, Gheorghe AS, Froicu EM, Dumitrescu EA, Gafton B, Alexa-Stratulat T, Miron L, Stănculeanu DL, Marinca MV.
Long-Term Survival in BRCA1 Mutant Advanced Ovarian Cancer: Unveiling the Impact of Olaparib. Diagnostics. 2024; 14(17):1898.
https://doi.org/10.3390/diagnostics14171898
Chicago/Turabian Style
Afrăsânie, Vlad-Adrian, Alexandra Rusu, Adelina Silvana Gheorghe, Eliza Maria Froicu, Elena Adriana Dumitrescu, Bogdan Gafton, Teodora Alexa-Stratulat, Lucian Miron, Dana Lucia Stănculeanu, and Mihai Vasile Marinca.
2024. "Long-Term Survival in BRCA1 Mutant Advanced Ovarian Cancer: Unveiling the Impact of Olaparib" Diagnostics 14, no. 17: 1898.
https://doi.org/10.3390/diagnostics14171898
APA Style
Afrăsânie, V.-A., Rusu, A., Gheorghe, A. S., Froicu, E. M., Dumitrescu, E. A., Gafton, B., Alexa-Stratulat, T., Miron, L., Stănculeanu, D. L., & Marinca, M. V.
(2024). Long-Term Survival in BRCA1 Mutant Advanced Ovarian Cancer: Unveiling the Impact of Olaparib. Diagnostics, 14(17), 1898.
https://doi.org/10.3390/diagnostics14171898
